Alzheimer Disease Research at the HIHG

Alzheimer disease is the flagship research area at the John P. Hussman Institute for Human Genomics (HIHG). Our world-renowned efforts to identify the genes that contribute to (and protect against) all forms of dementia are spearheaded by our Director, Dr. Margaret A. Pericak-Vance.

Her unwavering commitment to addressing health disparities in genomic medicine is what makes the HIHG unique.

Everyone, regardless of race, ethnicity, or socioeconomic status, should have access to personalized medicine. That is why diversity is one of our main foci when recruiting people to participate in our research.

Visit the pages on the left-hand sidebar to learn more about our Alzheimer disease studies that cover all groups and ethnicities, including African American, Puerto Rican, Cuban, and Peruvian populations. We invite you to get involved in this important research. Your participation will help ensure that future therapies to treat or prevent Alzheimer disease and related dementias will benefit all people.

Did you know?

  • Approximately 5 million people in the U.S. have Alzheimer disease and this number will likely increase to about 14 million by 2060
  • The same genetic factors do not necessarily carry the same level of risk in different populations.
  • For precision/personalized medicine to work, we must involve all types of people in genomics research

The Researchers Changing the Game